Andrew J. Murphy, EVP Research at REGENERON PHARMACEUTICALS, INC. (REGN), sold 26,363 shares at $1142.94 ($30.2M) on 2024-08-14, disclosed to the SEC on 2024-08-15.
Scheduled sale ($30.2M) by EVP Research under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1141.49 | 13,637 | $15.6M | 51.5% |
| 2 | $1140.31 | 55 | $63K | 0.2% |
| 3 | $1140.31 | 55 | $63K | 0.2% |
| 4 | $1142.94 | 48 | $55K | 0.2% |
| 5 | $1142.94 | 48 | $55K | 0.2% |
| 6 | $1143.28 | 79 |
| $90K |
| 0.3% |
| 7 | $1143.28 | 79 | $90K | 0.3% |
| 8 | $1144.89 | 45 | $52K | 0.2% |
| 9 | $1144.89 | 45 | $52K | 0.2% |
| 10 | $1145.58 | 148 | $170K | 0.6% |
| 11 | $1145.58 | 148 | $170K | 0.6% |
| 12 | $1146.60 | 51 | $58K | 0.2% |
| 13 | $1146.60 | 51 | $58K | 0.2% |
| 14 | $1148.52 | 537 | $617K | 2.0% |
| 15 | $1148.52 | 537 | $617K | 2.0% |
| 16 | $1149.60 | 294 | $338K | 1.1% |
| 17 | $1149.60 | 294 | $338K | 1.1% |
| 18 | $1150.41 | 844 | $971K | 3.2% |
| 19 | $1150.41 | 844 | $971K | 3.2% |
| 20 | $1151.46 | 185 | $213K | 0.7% |
| 21 | $1151.46 | 185 | $213K | 0.7% |
| 22 | $1152.36 | 197 | $227K | 0.8% |
| 23 | $1152.36 | 197 | $227K | 0.8% |
| 24 | $1153.74 | 987 | $1.1M | 3.8% |
| 25 | $1153.74 | 987 | $1.1M | 3.8% |
| 26 | $1154.66 | 777 | $897K | 3.0% |
| 27 | $1154.66 | 777 | $897K | 3.0% |
| 28 | $1155.76 | 402 | $465K | 1.5% |
| 29 | $1155.76 | 402 | $465K | 1.5% |
| 30 | $1156.43 | 1,016 | $1.2M | 3.9% |
| 31 | $1156.43 | 1,016 | $1.2M | 3.9% |
| 32 | $1157.41 | 178 | $206K | 0.7% |
| 33 | $1157.41 | 178 | $206K | 0.7% |
| 34 | $1158.78 | 189 | $219K | 0.7% |
| 35 | $1158.78 | 189 | $219K | 0.7% |
| 36 | $1159.69 | 331 | $384K | 1.3% |
| 37 | $1159.69 | 331 | $384K | 1.3% |
| Total | $1147.12 avg | 26,363 | $30.2M | 100% |
| Filing → |
| REGN | SELL | 2023-12-06 | $10.6M | — | Filing → |
| REGN | SELL | 2023-11-15 | $10.3M | — | Filing → |
| REGN | SELL | 2022-11-16 | $5.2M | — | Filing → |